A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Massachusetts General Hospital
Ossium Health, Inc.
Institute of Hematology & Blood Diseases Hospital, China
Ohio State University Comprehensive Cancer Center
Children's Hospital of Philadelphia
UNC Lineberger Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Affiliated Hospital of Qinghai University
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
City of Hope Medical Center
Medical College of Wisconsin
Children's Hospital of Philadelphia